Skip to content
Clinical Trials – home

Fluvastatin: A Comprehensive Guide for Patients

1 / 2
trials open to patients / all trials
2+
Countries

In short

Fluvastatin, a medication primarily used to lower cholesterol levels, has been the subject of numerous clinical trials exploring its potential benefits in various medical conditions. These trials have investigated the drug's effects on lipid metabolism disorders, cardiovascular health, and even its potential in treating certain types of cancer. This article summarizes key findings from clinical trials using Fluvastatin, providing insights into its efficacy, safety, and potential new applications in medical treatment.

At a glance

Primary Uses
Treatment of hypercholesterolemia and mixed dyslipidemia
Dosage Range
20 mg to 80 mg daily, sometimes in extended-release formulations
Key Outcomes Measured
LDL-C reduction, total cholesterol reduction, cardiovascular events
Additional Conditions Studied
Antiphospholipid syndrome, brown adipose tissue activity, heart transplantation, aortic stenosis, graft vasculopathy, optico-chiasmatic gliomas
Common Side Effects Monitored
Muscle pain, liver enzyme elevations, blood glucose changes
Trial Durations
Ranging from several weeks to one year
Potential New Applications
Anti-inflammatory effects, immunomodulation, cancer treatment (in combination with other drugs)

What is Fluvastatin?

Fluvastatin is a medication that belongs to a class of drugs called statins. It's also known by the brand names Lescol and Lescol XL. Statins are primarily used to lower cholesterol levels in the blood, but they have other beneficial effects as well.

Uses of Fluvastatin

Fluvastatin is prescribed for several conditions:

  • High Cholesterol: It's primarily used to treat primary hypercholesterolemia (high levels of cholesterol in the blood) or mixed dyslipidemia (abnormal levels of fats in the blood).
  • Cardiovascular Risk Reduction: Fluvastatin is used in patients with moderate to high cardiovascular risk who haven't achieved their lipid (fat) goals with lower doses.
  • Antiphospholipid Syndrome (APS): It's being studied for its potential to reduce the risk of cardiovascular disease and blood clots in patients with APS, a disorder that can cause blood clots.
  • After Heart Transplantation: Fluvastatin is used in heart transplant recipients to improve survival rates.
  • After Kidney Transplantation: It's used to prevent cardiovascular events in kidney transplant patients.

How Fluvastatin Works

Fluvastatin works by inhibiting an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the body. By blocking this enzyme, Fluvastatin reduces the amount of cholesterol produced, particularly low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol.

In addition to its cholesterol-lowering effects, Fluvastatin may have other beneficial properties:

  • Anti-inflammatory effects: It may help reduce inflammation in the body, which is associated with various diseases.
  • Anti-thrombotic effects: It might help prevent blood clots.

Dosage and Administration

Fluvastatin is available in different forms and dosages:

  • Extended Release Tablets: 80 mg once daily
  • Immediate Release Capsules: 40 mg twice daily
  • Other dosages: Some studies have used 40 mg daily

The specific dosage and frequency will be determined by your doctor based on your individual needs and condition. Always follow your doctor's instructions carefully.

Potential Side Effects

Like all medications, Fluvastatin can cause side effects, although not everyone experiences them. Some potential side effects include:

  • Muscle pain or weakness: This is a common side effect of statins. If you experience unexplained muscle pain, tenderness, or weakness, contact your doctor immediately.
  • Liver enzyme elevations: Your doctor may monitor your liver function while you're taking Fluvastatin.
  • Increased blood sugar levels: Some studies suggest that statins may slightly increase the risk of developing type 2 diabetes.

Your doctor will monitor you for these and other potential side effects during your treatment.

Ongoing Research

Researchers are continually studying Fluvastatin to understand its full range of effects and potential uses:

  • Brown Adipose Tissue: Studies are investigating how Fluvastatin affects brown fat activity and its potential impact on insulin resistance.
  • Aortic Stenosis: Research is being conducted to see if Fluvastatin can slow the progression of aortic valve stenosis, a condition where the heart's aortic valve narrows.
  • Hepatitis C: Some studies are exploring whether Fluvastatin might have effects against the hepatitis C virus.
  • Metabolic Syndrome: Researchers are investigating other potential effects of Fluvastatin in patients with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.

It's important to note that these are areas of ongoing research, and Fluvastatin is not currently approved for treating these conditions unless specifically prescribed by your doctor.

Questions people often ask

Conditions where Fluvastatin is being studied

Each condition opens its own overview and trial list

Trials with Fluvastatin

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).